Barclays Prefers China Discretionary Over Staples Before NPC

Barclays Plc said investors should buy Chinese consumer directionary stocks over consumer staples before this month’s meeting of the National People’s Congress, while avoiding health-care companies.

Real wage inflation may help consumers spend more on discretionary products, Barclays said in a report dated today. The analysts said government policies aimed at expanding hospital capacity and ensuring essential drugs are available at lower cost will be positive for patients and negative for companies such as Sinopharm Group Co. (1099)

Baidu Inc. and Sina Corp. are among Chinese Internet companies that will benefit from growth in e-commerce and a shift in advertising budgets to online video from television because of new regulations limiting entertainment programs, they said.

To contact the editor responsible for this story: Allen Wan at awan3@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.